Sector Focus | Core Technology: Radiopharmaceutical drug development alongside medical radioisotope production and supply.
Mission Statement | Company Vision: ITM’s vertically integrated business model – from isotope production to drug development – is based on one mission: to improve outcomes for people living with hard-to-treat cancer. Leveraging 20 years of expertise, ITM has become a cornerstone of the radiopharmaceutical industry focused on transforming cancer care by combining world-class medical isotope manufacturing with the development of cutting-edge diagnostic and targeted therapies.

Products | Services:

• Targeted radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors
• High-quality medical radioisotope production and distribution
• Radiolabelling and quality control equipment

Target Market | Application Area: We are committed to serving the radiopharmaceutical industry – including our global partners, clinicians and cancer patients – by developing targeted radiopharmaceuticals and supplying our high-quality medical radioisotopes.
Unique Selling Proposition (USP): We stand apart in the radiopharmaceutical industry by integrating both isotope manufacturing and clinical expertise under one roof. This ‘production-to-patient’ approach delivers clear benefits for our company, our customers, and – most importantly – patients. It also creates significant value for our investors.